Literature DB >> 8141452

Toxicity of compound A in rats. Effect of a 3-hour administration.

C T Gonsowski1, M J Laster, E I Eger, L D Ferrell, R L Kerschmann.   

Abstract

BACKGROUND: Soda lime converts sevoflurane to CF2 = C(CF3)OCH2F, an olefin called compound A, whose toxicity raises concerns regarding the safe administration of sevoflurane via rebreathing circuits. The present report extends the findings of a previous investigation by others of the toxicity of this olefin, and establishes concentration-response relationships for such toxicity.
METHODS: Eighteen groups of ten Wistar rats breathed 0, 25, 50, 100, 200, 300, 350, and 400 ppm of the olefin in oxygen for 3 h. The olefin concentrations were developed in a square-wave manner by injection of saturated vapor followed by a continuous delivery of dilute vapor. The lethal concentration in 50% (LC50) of animals was estimated by logistic regression. Rats were killed on day 1 or day 4 after breathing the olefin, and specimens of brain, kidney, lung, liver, and small intestine were obtained from all rats for examination using light microscopy.
RESULTS: The LC50 equaled 331 ppm (95% confidence limits +/- 13 ppm). No injury resulted to lung or small intestine in either the experimental or the control group (those breathing only oxygen for 3 h). Renal injury (necrosis of the outer strip of the outer medulla, defined in this report as corticomedullary tubular necrosis) occurred at 50 ppm and greater; hepatic injury at 350 ppm and greater; and cerebral injury only at 400 ppm.
CONCLUSIONS: The lethal concentration and the threshold for toxicity of the olefin are less than previously reported. The threshold for nephrotoxicity reaches the range of values for the olefin that have been attained in clinical practice. Further studies are required to determine whether these results in rats can be extrapolated to patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8141452     DOI: 10.1097/00000542-199403000-00012

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  17 in total

1.  Association of Surgery and Anesthesia With Mental Disorder Diagnoses: What Would Sir Austin Bradford Hill Say?

Authors:  Olubukola O Nafiu; Peter J Davis
Journal:  Anesth Analg       Date:  2017-12       Impact factor: 5.108

Review 2.  Safety considerations in the use of drug combinations during general anaesthesia.

Authors:  E S Ransom; R A Mueller
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

3.  RE: Yuge O: Renal toxicity of compound A with sevoflurane anesthesia: the benefits of sevoflurane appear to outweight the risks (editorial).J. Anesth 11:1-2.

Authors:  Edmond I Eger; Jackie L Martin
Journal:  J Anesth       Date:  1997-12       Impact factor: 2.078

4.  Humidification during low-flow anesthesia in children.

Authors:  Yuri Nakae; Dai Horikawa; Keiko Tamiya; Akiyoshi Namiki
Journal:  J Anesth       Date:  1998-12       Impact factor: 2.078

5.  Renal toxicity of compound A with sevoflurane anesthesia: The benefits of sevoflurane appear to outweigh the risks.

Authors:  Osafumi Yuge
Journal:  J Anesth       Date:  1997-03       Impact factor: 2.078

Review 6.  The introduction of new drugs into anaesthetic practice: a perspective in pharmaceutical development and regulation.

Authors:  I Gilron
Journal:  Can J Anaesth       Date:  1995-06       Impact factor: 5.063

7.  Comparison between low flow sevoflurane anesthesia and total intravenous anesthesia during intermediate-duration surgery: effects on renal and hepatic toxicity.

Authors:  S H Sahin; S O Cinar; I Paksoy; N Sut; S Oba
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

8.  Effect of sevoflurane anesthesia on the severity of renal histopathologic changes in rabbits pretreated with gentamicin: A controlled, investigator-blinded, experimental study.

Authors:  Azize Bestas; Mustafa Kemal Bayar; Nusret Akpolat; Mehmet Nihat Okuducu
Journal:  Curr Ther Res Clin Exp       Date:  2006-11

9.  Studies of the mechanism of nephrotoxicity of compound A in rats.

Authors:  J L Martin; L Kandel; M J Laster; R L Kerschmann; E I Eger
Journal:  J Anesth       Date:  1997-03       Impact factor: 2.078

Review 10.  Clinical pharmacokinetics of sevoflurane.

Authors:  M Behne; H J Wilke; S Harder
Journal:  Clin Pharmacokinet       Date:  1999-01       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.